|
Volumn 63, Issue 2, 1995, Pages 231-237
|
A recombinant vaccinia virus expressing human prostate‐specific antigen (PSA): Safety and immunogenicity in a non‐human primate
a a a a b b c c a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CANCER VACCINE;
PROSTATE SPECIFIC ANTIGEN;
RECOMBINANT VACCINE;
ARTICLE;
CONTROLLED STUDY;
IMMUNOGENICITY;
INTRADERMAL DRUG ADMINISTRATION;
MALE;
NONHUMAN;
PRIORITY JOURNAL;
PROSTATE CANCER;
RHESUS MONKEY;
VACCINIA VIRUS;
VIRUS RECOMBINANT;
ANIMAL;
ANTIBODIES, NEOPLASM;
BASE SEQUENCE;
CLONING, MOLECULAR;
DNA PRIMERS;
DNA, COMPLEMENTARY;
HUMAN;
IMMUNOGLOBULIN M;
LYMPHOCYTE ACTIVATION;
MACACA MULATTA;
MOLECULAR SEQUENCE DATA;
PROSTATE-SPECIFIC ANTIGEN;
RECOMBINANT PROTEINS;
VACCINES, SYNTHETIC;
VACCINIA VIRUS;
|
EID: 0028846857
PISSN: 00207136
EISSN: 10970215
Source Type: Journal
DOI: 10.1002/ijc.2910630215 Document Type: Article |
Times cited : (104)
|
References (30)
|